Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 496,000 | 408,500 | 303,800 | 74,400 | 247,100 |
| Depreciation Amortization | 245,100 | 181,200 | 120,500 | 59,400 | 254,700 |
| Income taxes - deferred | 54,700 | 16,600 | 37,200 | 26,200 | -57,600 |
| Accounts receivable | -18,000 | 3,800 | -121,600 | -28,300 | 134,500 |
| Accounts payable and accrued liabilities | 44,700 | 10,900 | 8,700 | 900 | 54,300 |
| Other Working Capital | -43,600 | -116,400 | -231,700 | -292,800 | 301,200 |
| Other Operating Activity | -8,300 | -15,500 | 84,300 | 88,200 | -67,900 |
| Operating Cash Flow | $770,600 | $489,100 | $201,200 | $-72,000 | $866,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -80,600 | 23,800 | 22,200 | -31,400 | -141,600 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -121,900 |
| Sale Of Investment | N/A | N/A | 0 | 0 | 58,400 |
| Other Investing Activity | 7,600 | 7,600 | 7,600 | 7,600 | -8,100 |
| Investing Cash Flow | $-73,000 | $31,400 | $29,800 | $-23,800 | $-213,200 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,300 | -27,500 | 7,500 | 9,400 | 11,100 |
| Debt Issued | N/A | N/A | N/A | N/A | 895,800 |
| Debt Repayment | -166,500 | -166,500 | -166,500 | -7,100 | -1,194,300 |
| Common Stock Issued | 40,600 | 12,000 | 8,800 | 7,800 | 6,900 |
| Dividend Paid | -121,000 | -89,000 | -59,800 | -29,000 | -152,200 |
| Other Financing Activity | -2,900 | -4,300 | -5,200 | -5,900 | 400 |
| Financing Cash Flow | $-248,500 | $-275,300 | $-215,200 | $-24,800 | $-432,300 |
| Exchange Rate Effect | -1,600 | 8,800 | -16,700 | -6,900 | 33,100 |
| Beginning Cash Position | 364,800 | 417,200 | 417,200 | 417,200 | 122,200 |
| End Cash Position | 811,500 | 671,200 | 416,300 | 289,700 | 364,800 |
| Net Cash Flow | $446,700 | $254,000 | $-900 | $-127,500 | $242,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 770,600 | 489,100 | 201,200 | -72,000 | 866,300 |
| Capital Expenditure | -223,000 | -111,000 | -68,900 | -32,000 | -157,500 |
| Free Cash Flow | 547,600 | 378,100 | 132,300 | -104,000 | 708,800 |